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Antifungal activityAbstract A series of 1,4-disubstituted 1,2,3-triazoles having p-substituted aromatic ester function-
ality were synthesized via Cu(I) catalysed click reaction between p-substituted benzoic acid prop-2-
ynyl esters and aralkyl azides. The synthesized triazoles were characterized by IR, 1H NMR, 13C
NMR and mass spectral techniques. These compounds were evaluated for their antimicrobial activ-
ity against Escherichia coli, Staphylococcus aureus, Bacillus subtilis, Pseudomonas aeruginosa,Myco-
bacterium tuberculosis, Candida albicans, Aspergillus niger and Aspergillus ﬂavus by two fold serial
dilution method. Some of the synthesized 1,4-disubstituted 1,2,3-triazoles possess comparable or
even better antibacterial, antitubercular and antifungal activities than reference drugs against tested
bacterial, mycobacterial and fungal strains, respectively.
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The synthesis of substituted 1,2,3-triazoles is of key impor-
tance due to their large biological spectrum as antibiotic(Aufort et al., 2008), antimicrobial (Lal et al., 2012; Gaur
et al., 2012; Demaray et al., 2008), antimalarial (D’hooghe
et al., 2011), anticancer (Salmon et al., 2012), antihistaminic
(Buckle et al., 1986), anti-HIV (Whiting et al., 2006) and anti-
tubercular agents (Labadie et al., 2011). Good stability and
high aqueous solubility of these compounds in biological sys-
tem boost for appreciable biological activities. Further the
1,4-disubstituted 1,2,3-triazoles have also been used as ligation
tool for the synthesis of neoglyco-conjugates (Perez-Balderas
et al., 2003), multivalent dendrimeric peptides (Wu et al.,
2004), ionic receptors (Kumar and Pandey, 2008), triazolo-
phanes (Haridas et al., 2008), dendrimers (Haridas et al.,
866 C.P. Kaushik et al.2007), cyclic peptides (Turner et al., 2007), peptide nanotubes
(Horne et al., 2003), peptidomimetics (Angell and Burgess,
2007) etc. Huisgen cycloaddition, the general method for the
synthesis of 1,4-disubstituted 1,2,3-triazoles includes a
1,3-dipolar cycloaddition between azides and alkynes under
thermal conditions to afford the equal mixture of 1,4- and
1,5-disubstituted isomers (Huisgen, 1963). A practical solution
to avoid the formation of isomeric mixture in products, was
given by Sharpless (Rostovtsev et al., 2002) and Meldal (Tor-
nøe et al., 2002) through the catchy term ‘‘click chemistry’’
which refers to facile, efﬁcient, selective and versatile chemical
transformation of reactant to a single isomeric product. These
reactions are simple to perform, modular, high yielding and
lead to excellent selectivity in the product. Among various
reactions, Cu(I) catalysed variant of Huisgen 1,3-dipolar
cycloaddition of azides and terminal alkynes to give only
1,4-disubstituted 1,2,3-triazoles has been generally pointed as
the primary standard of click chemistry. Herein, we report
the synthesis of a series of 1,4-disubstituted 1,2,3-triazoles
(3a–3p) from various azides and alkynes containing p-substi-
tuted aromatic ester functionalities. All the synthesized
1,4-disubstituted 1,2,3-triazoles were characterized by IR, 1H
NMR, 13C NMR spectroscopy and mass spectrometry and
also screened for their antibacterial, antitubercular and anti-
fungal activities.
2. Experimental
2.1. Measurements
Melting points of synthesized compounds were recorded in C
by applying open capillary method and are uncorrected. The
IR spectra were recorded on Shimazdu IR Afﬁnity-I FT-IR
spectrophotometer using potassium bromide (KBr) powder
and values are given in cm1. The 1H NMR spectra were
recorded on Bruker Avance II 400 MHz/Bruker 300 MHz
spectrophotometer and 13C NMR on Bruker Avance II 400
at 100 MHz/Bruker 300 at 75 MHz, in deuterated chloroform
using tetramethylsilane (TMS) as an internal standard (chem-
ical shift in d, ppm). Coupling constant (J) values are given in
Hertz (Hz). Mass spectra were recorded on a Waters Micro-
mass Q-Tof Micro (ESI) spectrophotometer. The completion
of reactions and the purity of the compounds were analysed
by thin layer chromatography (TLC) using readymade silica
gel plates (SIL G/UV254, ALUGRAM) and visualized under
ultraviolet lamp.
2.2. General procedure for the synthesis of 1,4-disubstituted
1,2,3-triazoles
The starting reactants p-substituted benzoic acid prop-2-ynyl
esters (2) were prepared by reacting p-substituted benzoyl chlo-
rides (1) and propargyl alcohol in the presence of N,N-dimeth-
ylaminopyridine (DMAP) in dry dichloromethane at 0–10 C.
The 1,4-disubstituted 1,2,3-triazoles (3a–3p) were synthesized
by stirring p-substituted benzoic acid prop-2-ynyl esters
(1 mmol) with different aralkyl bromides (1 mmol) in the pres-
ence of sodium azide (3 mmol), copper sulphate pentahydrate
(0.10 mmol) and sodium ascorbate (0.20 mmol) using
N,N-dimethylformamide:water (8:2) mixture as solvent at
room temperature for 6–12 h (Scheme 1).The reaction workupwas carried out with aqueous ammonia-
ammonium chloride solution and the compound was extracted
three times with ethyl acetate. The organic layer was dried over
anhydrous sodium sulphate, ﬁltered and concentrated under vac-
uum to yield 1,4-disubstituted 1,2,3-triazoles.
2.3. Characterization of synthesized compounds
2.3.1. 4-Methylbenzoicacid-1-benzyl-1H-[1,2,3]triazol-4-
ylmethylester (3a)
Appearance: white, crystalline solid; Yield: 82%; m.p. 118–
120 C; FT-IR (KBr): 3105 (C–H str., triazole ring), 3051,
2962, 1712, 1610, 1446, 1394 cm1; 1H NMR (400 MHz,
CDCl3, d): 2.41 (s, 3H), 5.45 (s, 2H), 5.55 (s, 2H), 7.23 (d, 2H,
J= 8 Hz), 7.28–7.31 (m, 3H), 7.38 (d, 2H, J= 12 Hz), 7.62
(s, 1H), 7.93 (d, 2H, J= 8 Hz); 13C NMR (100 MHz, CDCl3,
d): 21.7, 54.3, 57.9, 123.8, 127, 128.2, 128.9, 129.2, 129.8,
134.4, 143.4, 144, 166.5; MS m/z: 308.0 [M+], 309.0 [M+ + 1].
2.3.2. 4-Methylbenzoicacid-1-(phenylpropyl)-1H-
[1,2,3]triazol-4-ylmethylester (3b)
Appearance: off-white solid; Yield: 65%; m.p. 90–92 C; FT-
IR (KBr): 3116 (C–H str., triazole ring), 3068, 2943, 1712,
1610, 1448, 1400 cm1; 1H NMR (300 MHz, CDCl3): 2.17–
2.24 (m, 2H), 2.39 (s, 3H), 2.64 (t, 2H), 4.32 (t, 2H), 5.43 (s,
2H), 7.12–7.30 (m, 7H), 7.64 (s, 1H), 7.92 (d, 2H, J= 8 Hz);
13C NMR (75 MHz, CDCI3): 21.7, 36.8, 51.7, 57.9, 124.3,
127, 127.1, 128.7, 128.8, 129.1, 129.8, 136.9, 142.8, 143.9,
166.5; MS m/z: 336.0 [M+], 337.0 [M+ + 1].
2.3.3. 4-Methylbenzoicacid-1-(4-methylbenzyl)-1H-
[1,2,3]triazol-4-ylmethylester (3c)
Appearance: creamy-white, crystalline solid; Yield: 68.5%. m.p.
104–106 C; FT-IR (KBr): 3132 (C–H str., triazole ring), 3032,
2954, 2920, 1714, 1610, 1512, 1444 cm1. 1H NMR (400 MHz,
CDCl3): 2.35 (s, 3H), 2.40 (s, 3H), 5.43 (s, 2H), 5.50 (s, 2H),
7.00–7.28 (m, 6H), 7.60 (s, 1H), 7.92 (d, 2H, J= 8 Hz); 13C
NMR (100 MHz, CDCI3): 21.2, 21.7, 53.9, 54.1, 57.9, 123.7,
127, 127.2, 128.2, 129.1, 129.2, 129.8, 131.4, 138.8, 143.4,
143.9, 166.5; MS m/z: 322.0 [M+], 323.0 [M++ 1].
2.3.4. 4-Methylbenzoicacid-1-(4-nitrobenzyl)-1H-
[1,2,3]triazol–4-ylmethylester (3d)
Appearance: white, crystalline solid; Yield: 62.4%; m.p. 170–
172 C; FT-IR (KBr): 3130 (C–H str., triazole ring), 3082,
2962, 1699, 1606, 1525, 1435, 1348 cm1; 1H NMR
(400 MHz, CDCl3): 2.40 (s, 3H), 5.46 (s, 2H), 5.65 (s, 2H),
7.23 (d, 2H), 7.43 (d, 2H, J= 8.4 Hz), 7.73 (s, 1H), 7.91 (d,
2H, J= 8.0 Hz), 8.23 (d, 2H, J= 8.4 Hz); 13C NMR
(100 MHz, CDCI3): 21.7, 53.2, 57.8, 124.1, 126.8, 129.2,
129.5,129.8, 141.4, 142.7, 144.1, 145.4, 148.1, 166.5; MS m/z:
353.0 [M+], 354.0 [M+ + 1].
2.3.5. 4-Methoxybenzoicacid-1-benzyl-1H-[1,2,3]triazol-4-
ylmethylester (3e)
Appearance: off-white solid; Yield: 79%; m.p. 118–120 C;
FT-IR (KBr): 3136 (C–H str., triazole ring), 3064, 2951,
1712, 1604, 1508, 1452, 1323 cm1; 1H NMR (300 MHz,
CDCl3): 3.82 (s, 3H), 5.39 (s, 2H), 5.50 (s, 2H), 6.86 (d, 2H,
J= 8 Hz), 7.28–7.33 (m, 5H), 7.60 (s, 1H), 7.95 (d, 2H,
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3c CH3 4-CH3-C6H5-CH2-
3d CH3 4-NO2-C6H5-CH2-
3e OCH3 C6H5-CH2-
3f OCH3 C6H5-CH2-CH2-CH2-
3g OCH3 4-CH3-C6H5-CH2-
3h OCH3 4-NO2-C6H5-CH2-
3i NO2 C6H5-CH2-
3j NO2 C6H5-CH2-CH2-CH2-
3k NO2 4-CH3-C6H5-CH2-
3l NO2 4-NO2-C6H5-CH2-
3m F C6H5-CH2-
3n F C6H5-CH2-CH2-CH2-
3o F 4-CH3-C6H5-CH2-
3p F 4-NO2- C6H5-CH2-
Scheme 1 Synthesis of 1,4-disubstituted 1,2,3-triazoles(3a–3p).
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113.54, 122.07, 130.73, 128.07, 129.09, 131.81, 134.44, 143.48,
163.45, 165.96; MS m/z: 324.0 [M+], 325.0 [M+ + 1].
2.3.6. 4-Methoxybenzoicacid-1-(phenylpropyl)-1H-
[1,2,3]triazol-4-ylmethylester (3f)
Appearance: creamy-white solid; Yield: 64%; m.p. 78–80 C;
FT-IR (KBr): 3109 (C–H str., triazole ring), 3070, 2947,1712, 1600, 1502, 1448, 1377 cm1; 1H NMR (300 MHz,
CDCl3): 2.13–2.29 (m, 2H, J= 7.2 Hz), 2.65 (t, 2H,
J= 7.2 Hz), 3.83 (s, 3H), 4.34 (t, 2H J= 7.2 Hz), 5.43 (s,
2H), 6.89 (d, 2H, J= 8.7 Hz), 7.14–7.30 (m, 5H), 7.65 (s,
1H), 7.99 (d, 2H, J= 8.7 Hz); 13C NMR (75 MHz, CDCI3):
31.6, 32.5, 49.6, 55.5, 57.9, 113.7, 122.2, 126.4, 128.3, 128.4,
128.6, 131.8, 140.0, 143.2, 163.6, 166.3; MS m/z: 352.0 [M+],
353.0 [M+ + 1].
868 C.P. Kaushik et al.2.3.7. 4-Methoxybenzoicacid-1-(4-methylbenzyl)-1H-
[1,2,3]triazol-4-ylmethylester (3g)
Appearance: dull-white solid; Yield: 69.4%; m.p. 108–110 C;
FT-IR (KBr): 3188 (C–H str., triazole ring), 3022, 2947,
2920, 1705, 1606, 1512, 1448 cm1; 1H NMR (300 MHz,
CDCl3): 2.34 (s, 3H, CH3), 3.84 (s, 3H, OCH3), 5.40 (s, 2H,
CH2), 5.47 (s, 2H, CH2), 6.88 (d, 2H, J= 8.7 Hz), 7.17–7.26
(m, 4H), 7.64 (s, 1H), 7.97 (d, 2H, J= 8.7 Hz); 13C NMR
(75 MHz, CDCI3): 21.2, 54.1, 55.4, 57.8, 113.6, 122.1, 128.2,
129.8, 131.4, 131.8, 138.8, 143.5, 163.5, 166.2; MS m/z: 338.0
[M+], 339.0 [M+ + 1].
2.3.8. 4-Methoxybenzoicacid-1-(4-nitrobenzyl)-1H-
[1,2,3]triazol-4-ylmethylester (3h)
Appearance: shiny creamy-white solid; Yield: 72.8%; m.p.
172–174 C; FT-IR (KBr): 3124 (C–H str., triazole ring),
3080, 2848, 1701, 1606, 1523, 1431, 1340 cm1; 1H NMR
(300 MHz, CDCl3): 3.84 (s, 3H), 5.43 (s, 2H), 5.63 (s, 2H),
6.88 (d, 2H, J= 8.7 Hz), 7.41 (d, 2H, J= 8.4 Hz), 7.70 (s,
1H), 7.96 (d, 2H, J= 8.7 Hz), 8.21 (d, 2H, J= 8.4 Hz); 13C
NMR (75 MHz, CDCI3): 51.52, 53.17, 55.46, 56.96, 57.66,
113.67, 121.89, 124.33, 128.69, 131.79, 141.41, 144.15, 148.10,
163.63, 166.19; MS m/z: 369.0 [M+], 370.0 [M+ + 1].
2.3.9. 4-Nitrobenzoicacid-1-benzyl-1H-[1,2,3]triazol-4-
ylmethylester (3i)
Appearance: creamy-white solid; Yield: 81%; m.p. 134–
136 C; FT-IR (KBr): 3124 (C–H str., triazole ring), 3076,
1726, 1604, 1521, 1435, 1350 cm1; 1H NMR (400 MHz,
CDCl3): 5.50 (s, 2H), 5.56 (s, 2H), 7.28–7.33 (m, 2H), 7.40–
7.41 (m, 3H),7.63 (s,1H), 8.21 (d, 2H J= 6.8 Hz), 8.29 (d,
2H J= 6.8 Hz); 13C NMR (100 MHz, CDCI3): 54.3, 58.8,
123.5, 124, 128.2, 129, 129.2, 130.9, 134.2, 135.1, 142.5,
164.6; MS m/z: 339.0 [M+], 340.0 [M++1].
2.3.10. 4-Nitrobenzoicacid-1-(phenylpropyl)-1H-[1,2,3]triazol-
4-ylmethylester (3j)
Appearance: off-white solid; Yield: 70.15%; m.p. 106–108 C;
FT-IR (KBr): 3124 (C–H str., triazole ring), 3076, 1722, 1606,
1516, 1454, 1348 cm1; 1H NMR (300 MHz, CDCl3): 2.27–
2.31 (m, 2H), 2.67 (t, 2H J= 6.9 Hz), 4.40 (t, 2H
J= 6.9 Hz), 5.52 (s, 2H), 7.15–7.32 (m, 5H), 7.9 (s, 1H),
8.26 (m, 4H); 13C NMR (75 MHz, CDCI3): 31.6, 32.5, 49.7,
58.8, 123.6, 126.5, 128.4, 128.7, 130.9, 135.1, 139.9, 142.1,
150.7, 164.6; MS m/z: 367.0 [M+], 368.0 [M+ + 1].
2.3.11. 4-Nitrobenzoicacid-1-(4-methyl-benzyl)-1H-
[1,2,3]triazol-4-ylmethylester (3k)
Appearance: off-white solid; Yield: 77.3%; m.p. 136–138 C;
FT-IR (KBr): 3116 (C–H str., triazole ring), 3066, 2951, 1722,
1606, 1521, 1442, 1350 cm1; 1H NMR (400 MHz, CDCl3):
2.37 (s, 3H), 5.49 (s, 2H), 5.51 (s, 2H), 7.21–7.28 (m, 4H), 7.61
(s, 1H), 8.21 (d, 2H, J= 8.8 Hz), 8.28 (d, 2H, J= 8.8 Hz); 13C
NMR (100 MHz, CDCI3): 21.2, 54.2, 58.8, 123.5, 123.8, 128.3,
129.9, 130.9, 142.4, 167.0; MSm/z: 353.0 [M+], 354.0 [M++ 1].
2.3.12. 4-Nitrobenzoicacid-1-(4-nitrobenzyl)-1H-[1,2,3]triazol-
4-ylmethylester (3l)
Appearance: very light yellow coloured solid; Yield: 79.9%;
m.p. 142–144 C; FT-IR (KBr): 3151 (C–H str., triazole ring),3078, 1724, 1606, 1541, 1436, 1352 cm1. 1H NMR (300 MHz,
CDCl3): 5.0 (s, 2H), 5.17 (s, 2H), 6.94 (d, 2H, J= 10), 7.66–
7.78 (m, 6H), 7.7 (s, 1H). 13C NMR (75 MHz, CDCI3):
53.14, 58.54, 123.51, 124.31, 128.69, 130.84, 134.90, 141.27,
142.98, 148.12, 150.65, 164.40; MS m/z: 384.0 [M+], 385.0
[M+ + 1].
2.3.13. 4-Flourobenzoicacid-1-benzyl-1H-[1,2,3]triazol-4-
ylmethylester (3m)
Appearance: white puffy solid; Yield: 85.3%; m.p. 98–100 C;
FT-IR (KBr): 3120 (C–H str., triazole ring), 3068, 1720, 1602,
1508, 1450, 1242 cm1; 1H NMR (400 MHz, CDCl3): 5.45 (s,
2H), 5.51 (s, 2H), 7.10 (t, 2H, J= 8.8 Hz), 7.28–7.32 (m,
3H), 7.38–7.40 (d, 2H), 7.62 (s, 1H), 8.04–8.07 (d, 2H); 13C
NMR (100 MHz, CDCI3): 54.3, 58.8. 115.6, 123.8, 126,
128.2, 128.9, 129.2, 132.3, 134.3, 143.2, 164.6, 165.5; MS m/
z: 312.0 [M+], 313.0 [M+ + 1].
2.3.14. 4-Flourobenzoicacid-1-(phenyl-propyl)-1H-
[1,2,3]triazol-4-ylmethylester (3n)
Appearance: white solid; Yield: 72.1%; m.p. 80–82 C; FT-IR
(KBr): 3111 (C–H, str., triazole ring), 3066, 1716, 1598, 1502,
1450, 1236 cm1; 1H NMR (400 MHz, CDCl3): 2.24–2.32 (m,
2H), 2.68 (t, 2H J= 7.2 Hz), 4.37 (t, 2H, J= 7.2 Hz), 5.50 (s,
2H), 7.12 (d, 2H, J= 8.4 Hz), 7.17–7.33 (m, 5H) 7.67 (s, 1H),
8.07 (d, 2H, J= 8.4 Hz); 13C NMR (100 MHz, CDCI3): 31.6,
32.5, 49.6, 58.2, 115.5, 115.7, 124.0, 126.0, 126.4, 128.4, 128.6,
132.3, 132.4, 140.0, 142.8, 164.6, 165.5, 167.2; MS m/z: 340.0
[M+], 341.0 [M+ + 1].
2.3.15. 4-Flourobenzoicacid-1-(4-methyl-benzyl)-1H-
[1,2,3]triazol-4-ylmethylester (3o)
Appearance: white solid; Yield: 76.0%; m.p. 108–110 C; FT-
IR (KBr): 3118 (C–H str., triazole ring), 3066, 2951, 1716,
1598, 1506, 1444, 1224 cm1; 1H NMR (400 MHz, CDCl3):
2.37 (s, 3H), 5.44 (s, 2H), 5.50 (s, 2H), 7.10 (dd, 2H,
J= 8.0), 7.22 (m, 4H), 7.59 (s,1H), 8.05 (dd, 2H, J= 8.0);
13C NMR (100 MHz, CDCI3): 21.2, 54.1, 58.1, 115.4, 115.7,
123.7, 126.0, 128.2, 129.8, 131.3, 132.3, 138.9, 143.1, 164.6,
165.5, 167.2; MS m/z: 326.0 [M+], 327.0 [M+ + 1].
2.3.16. 4-Flourobenzoicacid-1-(4-nitro-benzyl)-1H-
[1,2,3]triazol-4-ylmethylester (3p)
Appearance: light yellow solid; Yield: 79.3%; m.p. 122–
124 C; FT-IR (KBr): 3130 (C–H str., triazole ring), 3068,
1707, 1602, 1510, 1462, 1226 cm1; 1H NMR (300 MHz,
CDCl3): 5.40 (s, 2H), 5.66 (s, 2H), 7.08 (d, 2H, J= 8.0 Hz),
7.43 (d, 2H, J= 10.0 Hz), 7.74 (s, 1H), 8.03 (d, 2H,
J= 8.0 Hz), 8.20 (d, 2H, J= 10.0 Hz); 13C NMR (75 MHz,
CDCI3): 53.07, 57.90, 115.78, 124.26, 128.66, 132.39, 141.40,
143.61, 148.06, 163.33, 165.29, 168.40; MS m/z: 357.0 [M+],
358.0 [M+ + 1].
2.4. Determination of antimicrobial activities
2.4.1. Antibacterial/antitubercular activity evaluation
All the synthesized compounds were assessed for their in vitro
antibacterial activity against two gram negative bacteria, Esch-
erichia coli (MTCC 1231) and Pseudomonas aeruginosa
(MTCC 1036), two gram positive bacteria, Staphylococcus
Table 2 MIC (lg/ml) values of compounds 3a–3p for antifungal activity.
Compound no. C. albicans (MTCC 854) A. niger (MTCC 282) A. ﬂavus (MTCC 873)
3a 500 500 1000
3b 25 100 100
3c 50 25 50
3d 500 100 100
3e 500 250 125
3f 100 50 100
3g 200 100 100
3h 100 200 500
3i 500 200 250
3j 500 500 500
3k 250 200 100
3l 500 1000 500
3m 50 100 50
3n 12.5 12.5 25
3o 25 25 50
3p 100 100 200
Amphotericin B 25 25 50
Table 1 MIC (lg/ml) values of compounds 3a–3p for Antibacterial activity.
Compound no. E. coli
(MTCC 1231)
S. aureus
(MTCC 7443)
B. subtilis
(MTCC 9023)
P. aeruginosa
(MTCC 1036)
M. tuberculosis
(ATCC 27294)
3a 100 500 100 250 50
3b 25 12.5 12.5 12.5 12.5
3c 100 100 200 50 50
3d 100 250 200 250 12.5
3e 100 250 500 500 50
3f 50 200 100 200 25
3g 200 1000 500 500 25
3h 100 250 200 200 50
3i 100 200 250 100 25
3j 50 100 50 100 6.25
3k 100 500 50 200 50
3l 200 500 250 500 50
3m 500 500 100 250 12.5
3n 100 50 50 50 3.75
3o 100 100 100 100 25
3p 100 500 500 500 50
Ciproﬂoxacin 25 50 12.5 12.5 –
Isoniazid – – – – 3.75
Synthesis and antimicrobial evaluation of 1,4-disubstituted 1,2,3-triazoles 869aureus (MTCC 7443) and Bacillus subtilis (MTCC 9023). The
in vitro activities of newly synthesized triazoles were tested in
nutrient broth (NB, Hi-media, Mumbai) by two fold serial
dilution method using a stock solution of 1000 lg/ml concen-
tration. Dimethylsulphoxide was used as solvent control. The
stock solutions of test compounds and reference drug were
serially diluted to get concentrations of 500, 250, 200, 100,
50, 25 and 12.5 lg/ml. These dilutions were inoculated with
100 lL suspension of respective microorganisms in sterile sal-
ine and incubated at 37 C for 24 h. To check the effect of sol-
vent on bacterial growth, a control test was performed with the
test medium supplemented with dimethylsulphoxide at same
dilution as used in the experiment. The antibacterial potency
of the compounds was compared with a broad spectrum anti-
biotic ciproﬂoxacin.Mycobacterium tuberculosis (ATCC 27294) were assessed in
microtiter plates by adding 10 ml aliquots of a culture suspen-
sion [whose turbidity was equal to that of a No. 0.5 McFarland
standard containing 1.5 · 108 colony forming units (CFU)/ml]
to 80 ml of Middlebrook 7H9 medium containing 0.5% glyc-
erol and 10% albumin-dextrose-catalase (ADC) and various
concentrations of test compounds. Plates were then incubated
for 9 days at 37 C. At the end of incubation, the number of
viable mycobacterium was determined by the MTT method.
2.4.2. Antifungal activity evaluation
All synthesized triazole compounds were evaluated for their
in vitro antifungal activity against three fungal strains viz. Can-
dida albicans (MTCC 854), Aspergillus niger (MTCC 282),
Aspergillus ﬂavus (MTCC 873) and amphotericin B was used
870 C.P. Kaushik et al.as the standard drug. Sabouraud dextrose broth was employed
as culture media and dimethylsulphoxide as solvent control. A
spore suspension in sterile saline was prepared from one day
old culture of fungus growing on sabourauds dextrose broth
(SDB, Hi-Media, Mumbai). The ﬁnal spore concentration
was 100 lL/ml. The stock solutions of 1000 lg/ml of test com-
pounds and standard drug were diluted to get concentrations
of 500, 250, 200, 100, 50, 25 and 12.5 lg/ml. These dilutions
were inoculated with the suspension of respective microorgan-
ism in their culture media and were incubated at 25 C for 48 h
in case of C. albicans and at 25 C for 120 h in case of A. niger
and A. ﬂavus.
3. Results and discussion
3.1. Chemistry
The triazole compounds were characterized by IR, 1H NMR,
13C NMR and mass spectral techniques. The formation of tri-
azole was conﬁrmed by the presence of an absorption band in
the region 3188–3105 cm1 in IR spectra due to ‚C–H
stretching of triazole ring. The presence of characteristic sin-
glet in 1H NMR due to triazolyl protons in the region of d
7.59–7.9 and d 129.8–132.4 in 13C NMR due to C-5 of the tri-
azole ring conﬁrmed the formation of the triazole ring. The re-
sults obtained from mass spectral analysis were found to be in
accordance to their molecular weights.
3.2. Antibacterial/antitubercular activity
All compounds were assessed for their in vitro antibacterial/
antitubercular activity against E. coli, S. aureus, B. subtilis,
P. aeruginosa and M. tuberculosis. The antibacterial/ antitu-
bercular potency of the compounds was compared with stan-
dard drugs ciproﬂoxacin and isoniazid. The minimum
inhibitory concentration (MIC) values were calculated as sum-
marized in Table 1.
The results obtained from their antibacterial studies re-
vealed that compounds 3a to 3p showed moderate to excellent
activities against tested bacterial strains. Compound 3b
showed an excellent activity against both gram positive and
gram negative bacterial strains with MIC values ranging from
12.5–25 lg/ml. Compound 3j exhibited good to moderate
activity against E. coli, B. subtilis, M. tuberculosis and com-
pound 3n has better inhibition effect against S. aureus, B. sub-
tilis, P. aeruginosa and M. tuberculosis. Compounds 3c and 3f
were found to possess apparent activity against P. aeruginosa
and E. coli, respectively.
3.3. Antifungal activity
The in vitro antifungal activity of the synthesized compounds
was examined against three fungal strains viz. C. albicans,
A. niger, A. ﬂavus and Amphotericin B was used as the stan-
dard drug. The MIC values of the test compounds and the
standard are furnished in Table 2.
Antifungal activity results indicated that most of the syn-
thesized compounds exhibited good to moderate activity
against the tested fungal strains. The compounds 3c, 3n and
3o showed excellent antifungal activity against all tested fungal
strains with MIC values ranging from 12.5–50 lg/ml.Compounds 3b, 3f and 3m exhibited good antifungal activity
against C. albicans, A. niger and A. ﬂavus, respectively.
4. Conclusion
A series of 1,4-disubstituted 1,2,3-triazole compounds were
synthesized through an easy, convenient, Cu(I) catalysed click
reaction and evaluated for their in vitro antimicrobial activity
against E. coli, P. aeruginosa, S. aureus, B. subtilis, M. tubercu-
losis, C. albicans, A. niger and A. ﬂavus. Compound 3b exhib-
ited signiﬁcant antibacterial activity against all tested bacterial
strains, whereas, compounds 3n, 3o possess excellent anti-
fungal activity among the used fungal strains. Rest of synthe-
sized molecules have moderate to good antimicrobial activity.
The signiﬁcant antimicrobial activity of some of the synthe-
sized compounds highlights them as promising molecules for
further synthetic and biological exploration.Acknowledgements
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